Theratechnologies (Theratechnologies) Marketable Securities : $6.21 Mil (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Theratechnologies's Marketable Securities for the quarter that ended in Feb. 2024 was $6.21 Mil.

Theratechnologies's annual Marketable Securities declined from Nov. 2021 ($19.96 Mil) to Nov. 2022 ($9.21 Mil) and declined from Nov. 2022 ($9.21 Mil) to Nov. 2023 ($6.29 Mil).

Theratechnologies Marketable Securities Historical Data

The historical data trend for Theratechnologies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Marketable Securities Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Marketable Securities

Get a 7-Day Free Trial

11.96

8.03

19.96

9.21

6.29

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Marketable Securities	Get a 7-Day Free Trial															9.13	8.41	7.91	6.29	6.21

Theratechnologies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Theratechnologies (NAS:THTX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Theratechnologies Marketable Securities Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.